Document:

Exhibit 10.17

  

   

  

  
    THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY OTHER STATE OR JURISDICTION.  THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION
      STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT AND ANY APPLICABLE SECURITIES LAW OF ANY STATE OR OTHER JURISDICTION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

    

    

    	
            1,685,029 Series C Preferred Shares

          	
            Effective Date:
                September 21, 2017

          

    

    

    CIBUS GLOBAL, LTD.

    WARRANT TO PURCHASE SERIES C PREFERRED
            SHARES

    

    

    THIS WARRANT (the “Warrant”)
        between Cibus Global, Ltd., a company organized under the laws of the British Virgin Islands (the “Company”) and the undersigned holder of this Warrant (such
        person or entity and any successor and assign being hereinafter referred to as the “Holder”), sets forth the terms and conditions upon which the Holder is
        and shall be entitled, and shall and hereby does have the right, but not the obligation, to subscribe for and purchase from the Company 1,685,029 Series C Preferred Shares (such Series C Preferred Shares or other shares of capital stock for which
        this Warrant may in the future become exercisable for, the “Warrant Shares”) in the Company at an exercise price equal to US$2.10 per share (the “Exercise Price”).  This Warrant may be exercised from time to time and at any time in whole or in part prior to the Expiration Date (as defined below) and is
        subject to the terms and conditions set forth below.  The Holder acknowledges and agrees that the Warrant Shares, when and if issued upon exercise of the Warrant hereunder, shall be subject to the terms and conditions of the Company’s Amended and
        Restated Memorandum of Association (as the same may be amended, restated or otherwise modified from time to time, the “MOA”) and Articles of Association (as
        the same may be amended, restated or otherwise modified from time to time, the “AOA” and together with the MOA, the “Organizational Documents”).

    

    

    1. Term.  Subject to the terms
        and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, during the term commencing on the date hereof and concluding on the first to occur of the following (the “Expiration Date”): (a) September 21, 2027; or (b) any Qualified Liquidation/Change of Control Event (as such term is defined in the Organizational Documents).  In connection with a Qualified Liquidation/Change
        of Control Event, the Company will provide Holder with written notice specifying, as the case may be, the date on which such event will occur.  Such notice shall be delivered at least 15 days prior to the date therein specified for the occurrence
        of the Qualified Liquidation/Change of Control Event.  For the avoidance of doubt, a Qualified Public Offering (as such term is defined in the Organizational Documents) shall not constitute a Qualified Liquidation/Change of Control Event.

    

    

    2. Exercise.

    

    

    (i) In order to exercise this Warrant with respect to all or any portion of the Warrant Shares during the times when the
        Warrant is exercisable (as described above), the Holder (or in the case of exercise after the Holder’s death, the Holder’s executor, administrator, heir or legatee, as the case may be) must take the following actions:  (a) execute and deliver to
        the Company the Notice of Exercise in the form attached hereto as Exhibit “A” and incorporated herein by this reference (the “Notice of Exercise”), (b) agree to be bound by the terms and conditions of that Company’s Amended and Restated Registration Rights Agreement, dated as of September 19, 2017 (as such
        agreement may be amended, restated or otherwise modified from time to time, the “Registration Rights Agreement”) by executing and delivering to the Company a
        counterpart signature page to the Registration Rights Agreement, as well as such additional documents, instruments or agreements as the Company shall determine is reasonably necessary or appropriate in order to evidence or reflect any of the
        foregoing; and (c) pay the Exercise Price for the purchased Warrant Shares by either full payment, in cash or cash equivalents, or any other form which the Company may, in its sole and absolute discretion, approve at the time of exercise.  Payment
        of the Exercise Price shall immediately become due and shall accompany the Notice of Exercise.

    
      
        

    

    (ii) This Warrant may also be exercised by the Holder, in whole or in part, through a cashless exercise, as described in
        this Section 2(ii).  Notwithstanding any provisions herein to the contrary, if the fair market value of one Warrant Share is greater than the Exercise Price (at the date of calculation as set forth below), then in lieu of exercising this Warrant in
        cash, the Holder may elect to receive Warrant Shares equal to the value (as determined below) of this Warrant (or the portion thereof being cancelled) by surrender of this Warrant at the principal office of the Company, together with the properly
        endorsed Notice of Exercise and notice of such election, the Company shall issue to Holder a number of Warrant Shares, computed using the following formula:

    

    

    	 	
            X =

          	
            Y (A-B)

            A

          	 

    

    

    	
            Where

          	
            X =

          	
            The number of Warrant Shares to be issued to the Holder

          
	 	
            Y =

          	
            The number of Warrant Shares purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of
                the Warrant being exercised (at the date of such calculation)

          
	 	
            A =

          	
            The fair market value of one Warrant Share (at the date of such calculation)

          
	 	
            B =

          	
            Exercise Price (as adjusted to the date of such calculation)

          

    

    

    For purposes of the above calculation, the fair market value of one Warrant Share as of a particular date shall be
        determined as follows: (y) if traded on a national securities exchange, the fair market value shall be deemed to be the volume weighted average trading price of the Warrant Shares on such exchange for the five (5) trading days immediately prior to
        the date of exercise indicated in the Notice of Exercise (or if no reported sales took place on such day, the last date on which any such sales took place prior to the date of exercise); and (z) if traded over-the-counter only, the fair market
        value shall be deemed to be the average of the closing bid and asked prices over the five (5) trading days immediately prior to the date of exercise indicated in the Notice of Exercise (or if no reported sales took place on such day, the last date
        on which any such sales took place prior to the date of exercise).  If the Warrant Shares are not traded on the over-the-counter market or through a national securities exchange, this Warrant may be exercised by the Holder through a cashless
        exchange as described above but the fair market value per share of a Warrant Share shall be the price per share of a Warrant Share that the Company could obtain from a willing buyer for a Warrant Share sold by the Company as such price shall be
        determined in good faith by the Company’s Board of Directors.

    

    

    (iii) This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its
        surrender for exercise as provided above, and the person entitled to receive the Warrant Shares issuable upon such exercise shall be treated for all purposes as the holder of record of such Warrant Shares as of the close of business on such date. 
        In the event that this Warrant is exercised in part, the Company will execute and deliver a new Warrant of like tenor exercisable for the number of shares for which this Warrant may then be exercised.

    
      
        

    

    3. Replacement of Warrant.  On
        receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and
        substance to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

    

    

    4. No Impairment.  Except and
        to the extent as waived or consented to by the Holder, the Company will not, by amendment of its Organizational Documents or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
        other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at times in good faith assist in the carrying out of all the provisions of this Warrant
        and in the taking of all such action as may be necessary or appropriate in order to protect the exercise rights of the Holder against impairment.  Notwithstanding the foregoing, however, nothing hereunder shall be construed so as to prohibit the
        Company from undertaking further issuances of capital stock and/or such other securities or instruments, in each case, which may be exercisable or convertible with or into such capital stock in the Company, to one or more third-parties or other
        persons, such issuances to be upon such terms and conditions, and for such consideration as the Company shall deem to be appropriate, it being expressly acknowledged and agreed that any such issuances may dilute the percentage interests and/or
        other rights which may be represented by the Warrant Shares when and if they shall be issued upon exercise of the Warrants hereunder.

    

    

    5. No Member Rights; Limitation of Rights. 

        Prior to exercise of this Warrant, the Holder shall not be entitled to any economic rights of the Company with respect to any of the Warrant Shares.  Only upon proper and timely exercise of this Warrant as described hereunder, the Holder shall,
        with respect to the purchased Warrant Shares, have a right to share in distributions with respect to such Warrant Shares in the manner set forth in the Organizational Documents.

    

    

    6. Compliance with Securities Laws.

    

    

    (i) The Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant and the Warrant Shares (and any
        Voting Common Shares to be issued upon conversion thereof) to be issued upon exercise hereof are being acquired solely for the Holder’s own account and not as a nominee for any other party, and for investment, and that the Holder will not offer,
        sell, or otherwise dispose of this Warrant or any Warrant Shares (or any Voting Common Shares to be issued upon conversion thereof) to be issued upon exercise hereof or conversion thereof except under circumstances that will not result in a
        violation of the Securities Act, or any state securities laws.  Upon exercise of this Warrant, the Holder shall, if reasonably requested by the Company, confirm in writing, in a form reasonably satisfactory to the Company, that the Warrant Shares
        (and any Voting Common Shares to be issued upon conversion thereof) so purchased are being acquired solely for the Holder’s own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale.

    

    

    (ii) Holder further acknowledges that it is familiar with the definition of “accredited investor” in Rule 501 of
        Regulation D promulgated under the Securities Act and certifies that Holder is an accredited investor as defined in such rule.

    

    

    (iii) Holder understands that neither this Warrant nor the Warrant Shares (and any Voting Common Shares to be issued upon
        conversion thereof) have been registered under the Securities Act, and therefore they may not be sold, assigned or transferred unless (i) a registration statement under the Act is in effect with respect thereto or (ii) an exemption from
        registration is found to be available to the satisfaction of the Company.

    
      
        

    

    (iv) Holder understands that the Warrant Shares (and any Voting Common Shares to be issued upon conversion thereof) may be
        notated with one or more of the following legends:

    

    

    (a) “THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND
        HAVE BEEN ACQUIRED FOR INVESTMENT, AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.  NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM
        SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”

    

    

    (b) Any legend set forth in, or required by, the Organizational Documents.

    

    

    (c) Any legend required by the securities laws of any state to the extent such laws are applicable to
        the Warrant Shares (and any Voting Common Shares to be issued upon conversion thereof) represented by the certificate, instrument or book entry so legended.

    

    

    7. Certain Adjustments.

    

    

    (i) Reclassification.  If the
        Company, at any time while this Warrant, or any portion hereof, remains outstanding and unexpired, by the reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the
        same or a different number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the
        securities that were subject to the purchase rights under this Warrant immediately prior to such reclassification or other change and the Exercise Price therefore shall be appropriately adjusted, all subject to further adjustment as provided in
        this Section 7.

    

    

    (ii) Split, Subdivision or Combination. 

        If the Company at any time while this Warrant, or any portion hereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number of securities of
        the same class, the Exercise Price for such securities shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination and the number of shares subject to the Warrant shall be
        proportionately increased in the case of a split or subdivision and proportionately decreased in the case of a combination.

    

    

    (iii) Certificate as to Adjustment. 

        Upon the occurrence of each adjustment or readjustment pursuant to this Section 7 (other than Section 7(i)), the Company, at its expense, shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the
        Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based.

    
      
        

    

    8. Reservation of Shares.  The
        Company covenants that, beginning on the Effective Date, and during the remainder of the term this Warrant is exercisable, the Company will reserve from its authorized and unissued shares of capital stock a sufficient number of Series C Preferred
        Shares to provide for the issuance of Series C Preferred Shares upon the exercise of this Warrant.

    

    

    9. Market Stand-Off.  In
        connection with any underwritten public offering by the Company (or its successor) of its equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, Holder
        agrees that it shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise
        dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Warrant Shares acquired in connection with the exercise of this Warrant without the prior written consent of the Company and the Company’ s
        underwriters.  Such restriction (the “Market Standoff”) shall be in effect for such period of time following the date of the final prospectus for the
        offering as may be requested by the Company or such underwriters.  In no event, however, shall such period exceed 180 days.

    

    

    10. Additional Terms in connection with
            IPO.  The Warrant is hereby subject to such additional terms and conditions as are described in the IPO Addendum attached hereto as Exhibit C.

    

    

    11. Miscellaneous.

    

    

    (i) Governing Law. 

        This Warrant and all acts and transactions hereunder and all rights and obligations of Holder and Company shall be governed by the internal laws (and not the conflicts of law rules) of the British Virgin Islands.

    

    

    (ii) Assignment. 

        Neither this Warrant nor any of the rights, interests or obligations hereunder may be assigned, by operation of law or otherwise, in whole or in part by Holder to any person or entity without the prior written consent of the Company, in its sole
        and absolute discretion; provided, however, that Holder may without the prior written consent of the Company assign or transfer this Warrant
        during Holder’s lifetime or on Holder’s death by will or intestacy (but only with all related obligations) to (i) one or more of Holder’s affiliates (as such term is defined in Rule 501 of Regulation D promulgated under the Act) or (ii) Holder’s
        spouse or any of Holder’s other immediate family members or a trust for their benefit for estate planning purposes.  Upon any transfer or assignment of this Warrant, the Company may require, as a condition thereto, the payment of a sum sufficient
        to reimburse it for any transfer tax incidental thereto.  Any transfer shall be subject to (i) the transferee’s agreement in writing to be subject to the applicable terms of this Warrant, including, without limitation, executing the applicable
        agreements upon exercise of this Warrant in accordance herewith; (ii) compliance with all applicable state and federal securities laws (including the delivery of legal opinions reasonably satisfactory to the Company, if such are reasonably
        requested by the Company); and (iii) the execution and delivery to the Company of an Assignment Form in substantially the form attached hereto as Exhibit “B”. 

        This Warrant shall be binding upon any successors or assigns of the Company.

    

    

    (iii) Notices. 

        All notices, requests, demands and other communications hereunder (shall be in writing to the parties at the addresses set forth below the recipients’ signature to this Warrant, or at such other address as shall be given in writing by a party to
        the other parties, and shall be deemed to have been duly given at the earlier of (i) the time of actual delivery, (ii) the next business day after deposit with a nationally recognized overnight courier specifying next day delivery, with written
        verification of receipt, (iii) when delivered if sent electronically or via facsimile, or (iv) on the fifth (5th) business day following the date deposited with the United States Postal Service, postage prepaid, certified with return receipt
        requested.

    
      
        

    

    (iv) Enforcement. 

        The Company shall pay all reasonable fees and expenses, including reasonable attorney’s fees, incurred by Holder in the enforcement of any of the Company’s obligations hereunder not performed when due.

    

    

    (v) Amendment or
            Waiver.  Any provision of this Warrant may be amended or waived, but only pursuant to a written agreement signed by the Company and the Holder.

    

    

    (vi) General.
        Should any provision of this Warrant be held by any court of competent jurisdiction to be void or unenforceable, such defect shall not affect the remainder of this Warrant, which shall continue in full force and effect.  This Warrant and such other
        written agreements, documents and instruments as may be executed in connection herewith are the final, entire and complete agreement between Company and Holder and supersede all prior and contemporaneous negotiations and oral representations and
        agreements, all of which are merged and integrated in this Warrant.  There are no oral understandings, representations or agreements between the parties which are not set forth in this Warrant or in other written agreements signed by the parties in
        connection herewith.  This Warrant may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one agreement.  Each of the counterparts may be signed and transmitted by facsimile and/or
        PDF with the same validity as if it were an original document.

    

    

    [Signature Pages Follow]

    
      
        

    

    IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by a duly authorized officer and to be dated as of the
        date first above written.

    

    

    	
            “Company”

          	
            CIBUS GLOBAL LTD.

          
	 	 	 
	 	
            By:

          	/s/ Peter Beetham

          
	 	
            Name:

          	
            Peter Beetham

          
	 	
            Its:

          	
            CEO

          

    

    

    	 	
            Address:

          	
            6455 Nancy Ridge Drive, Suite 100

          
	 	 	
            San Diego, CA 92121

          

    

    

    
      [Signature Page to Warrant]

      
        
          

      

    

    	
            COUNTERPART SIGNATURE PAGE

          	 
	
            TO WARRANT

          	 
	 	 	 
	 	
            ACKNOWLEDGED AND AGREED TO:

          
	 	 	 
	 	
            HOLDER:

          
	 	 	 
	 	
            RORY RIGGS

          
	 	 	 
	 	
            By:

          	/s/ Rory Riggs

          
	 	
            Name:

          	RORY RIGGS

          
	 	
            Its:

          	 

    

    

    	 	
            Address:

          	 
	 	  
	 	  
	 	
            Email:

          
	 	
            Facsimile:

          

    

    

    [Signature Page to Warrant]

    
      
        

    

    EXHIBIT “A”

    

    

    NOTICE OF EXERCISE

    CIBUS GLOBAL LTD.

    WARRANT ORIGINALLY ISSUED _____________, 2017

    

    

    To: Cibus Global Ltd.

    

    

    
      
        	1.	
                The undersigned hereby (A) elects to purchase ______ Warrant Shares of Cibus Global Ltd. pursuant to the provisions of Section 2(i) of the attached Warrant,
                    and tenders herewith payment of the purchase price for such shares in the full amount of $____________, or (B) elects to exercise this Warrant with respect to ________________ of the Warrant Shares pursuant to the provisions of Section
                    2(ii) of the attached Warrant.

              

      

    

    

    

    
      
        	2.	
                In exercising this Warrant, the undersigned hereby confirms and acknowledges that the Warrant Shares are being acquired solely for the account of the
                    undersigned and not as a nominee for any other party, and for investment, and that the undersigned will not offer, sell or otherwise dispose of any such Series A Preferred Stock except under circumstances that will not result in a
                    violation of the Securities Act of 1933, as amended, or any applicable state securities laws.

              

      

    

    

    

    
      
        	3.	
                Please issue a new Warrant for the unexercised portion of the attached Warrant in the name of the undersigned or in such name as is specified below:

              

      

    

    

    

    	 	 
	 	
            (Name) (Please Print)

          

    

    

    	 	
            Social Security or other identifying Number:

          	 

    

    

    	 	
            Address:

          	 
	 	 	 
	 	

          	
             

              

            City, State and Zip Code

          

    

    

    	 	 	 
	
            (Date)

          	 	
            (Signature)

          

    
      
        

    

    EXHIBIT “B”

    

    

    ASSIGNMENT FORM

    

    

    (To assign the foregoing Warrant, execute

    this form and supply required information.)

    

    

    FOR VALUE RECEIVED, and subject to compliance with applicable federal and state securities laws (including the delivery of
        legal opinions satisfactory to the Company, if such are requested by the Company), an interest corresponding to the unpaid principal amount of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

    

    

    	 
	
            (Please Print)

          

    
      

      

    

    	
            whose address is

          	 

    

    

    	
            Dated:

          	 	 

    

    

    	
            Holder’s Signature:

          	 	 

    

    

    	
            Holder’s Address:

          	 	 
	 	 	 
	 	 	 

    

    

    	
            Signature Guaranteed:

          	 	 

    

    

    
      
        	NOTE:	
                The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change
                    whatever, and must be guaranteed by a bank or trust company.  Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

              

      

    

    

    

    The assignee of the Warrant, in connection with the execution of this Assignment Form, must execute and deliver an
        acknowledgment of, and agreement to be bound by, the terms of the Warrant and all other writings related thereto.

    
      
        

    

    EXHIBIT “C”

    

    

    IPO ADDENDUM

    

    

    The Warrant is hereby subject to the following additional terms and conditions:

    

    

    (a) “Up-C” IPO.  In the event
        that, in connection with any desired public offering of shares of the Company, the Company causes to be created an entity to serve as the vehicle to be used to accomplish the purposes of such offering (“IPOco”), which IPOco is established to sell shares directly to the public for cash and then contribute the cash proceeds from such offering to the Company in exchange for shares of the Company (with
        shares of the Company then being exchangeable for equivalent shares of IPOco on a one-for-one basis), the Warrant shall, upon designation by the Holder (at the Holder’s option), and to the extend not otherwise exercised or terminated, at the time
        of exercise of this Warrant, be exercisable against the Company in exchange for delivery by the Company to Holder of that number (and class) of IPOco shares into which the Warrant Shares are exchangeable, at the same exercise price as this Warrant,
        in each case subject to adjustment in the event the ratio at which the Company’s shares may be exchanged for shares in IPOco is other than one for one.

    

    

    (b) “Rollup” IPO.  In the
        event that the Company is reorganized, converted, merged or otherwise consolidated with or into a newly formed legal entity (a “Rollup Vehicle”) pursuant to
        which all or a significant portion of the holders of equity securities in the Company are offered and/or receive equity securities in such Rollup Vehicle, and, in connection with which, such Rollup Vehicle undertakes (or is contemplated to
        undertake) a public offering of equity securities (collectively, a “Rollup Transaction”), then the following additional provisions shall apply:

    

    

    (i) Exchange of Warrant.  The
        Warrant, to the extent not previously exercised or terminated hereunder, shall entitle the Holder (at the Holder’s option) to contribute and convey the Warrant (free and clear of any liens or encumbrances) to the Rollup Vehicle concurrently with
        such Rollup Transaction in exchange for a designated number of Exchange Shares (defined below) of the Rollup Vehicle.  The designated number of Exchange Shares shall be the same number of shares of the Rollup Vehicle as are issued in the Rollup
        Transaction to former holders of shares of the Company of the same class as the Warrant Shares in exchange for such shares (such shares of the Rollup Vehicle as are issued to such holders of such Company shares being referred to as the “Equivalent Shares”).  The Company and the Rollup Vehicle shall utilize commercially reasonable efforts (to the extent permissible in accordance with applicable
        law) in order for the contribution and conveyance of the Warrant by the holder thereof to the Rollup Vehicle in exchange for the Exchange Shares to be treated and classified for U.S. federal tax purposes as a transaction described in Section 351(a)
        of the Internal Revenue Code of 1986, as amended.

    

    

    (ii) Shares Issued in Exchange for
            Warrant.  The “Exchange Shares” of the Rollup Vehicle shall mean a class of equity securities of the Rollup Vehicle which are designated as a
        special class of securities in the Rollup Vehicle.  Each Exchange Share shall, except as otherwise described below, entitle the holder thereof to equivalent and parri passu voting and economic rights with respect to dividends and liquidating
        distributions from the Rollup Vehicle as are possessed by a holder of an Equivalent Share.

    
      
        

    

    (iii) Additional Terms of Exchange
            Shares.  Notwithstanding the foregoing, the organizational documents of the Rollup Vehicle shall provide the following additional terms and conditions relating to each Exchange Share:

    

    

    (A) Upon liquidation (or similar event) with respect to the Rollup Vehicle, such Exchange Share shall not be entitled to
        receive distributions in connection therewith unless and until the amounts that would have been distributable with respect to such Exchange Share (but which are no so distributed by reason of this clause) are equal to the unpaid exercise price for
        the Warrant Share(s) underlying the Warrant and for which such Exchange Share was issued (the “Unpaid Exercise Price”).

    

    

    (B) At any time on or prior to the date which is 7 years after the date of issuance of such Exchange Share (such period,
        the “Exchange Period”), the holder thereof shall have the option of converting such Exchange Share into a specified number (or fraction) of Equivalent
        Shares, such specified number (or fraction) being that number (or fraction) of Equivalent Shares as shall have an aggregate Fair Market Value as of that time which is equal to the Net Share Value.  The “Net Share Value” shall mean the Fair Market Value of an Equivalent Share as of the date of conversion minus the Unpaid Exercise Price of the Exchange Share being converted.  The “Fair Market Value” shall mean, as of any particular date, the trailing 30-day average closing sales price for such shares as quoted on the stock exchange or
        market on which shares are listed or, in the absence of such exchange or markets, as determined by the Board of Directors of the Rollup Vehicle in good faith.

    

    

    (C) At any time after the close of the Exchange Period, with respect to any Exchange Share which have not been converted
        into Equivalent Shares pursuant to the immediately preceding clause, the Rollup Vehicle shall have the right (but not the obligation) to purchase such Exchange Share (and the holder thereof shall be obligated to sell such Exchange Share to the
        Rollup Vehicle, free and clear of any liens or encumbrances) for a cash purchase price equal to the excess of the Net Share Value (defined above) as of such time minus the Full Share Value (as also defined above) as of such time.

    

    

    (D) Such additional terms and conditions as shall be determined by the Rollup Vehicle to be necessary or appropriate in
        order to evidence, reflect or give effect to any of the matters set forth above (including but not limited to such provisions as relate to time periods or procedures for giving notices of exercise, conversion or other similar matters, and/or such
        additional matters as may be necessary or appropriate in order to comply with any applicable, or potentially applicable, laws, rules, or regulations from time to time).Exhibit 10.18

   

   

  AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

  

  

  THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the 21ST day of September, 2017, by
      and among Cibus Global, Ltd., a British Virgin Islands company (the “Company”),

      and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Series C Purchase Agreement) or holder of Registrable Securities that
      becomes a party to this Agreement in accordance with Section 3.9 hereof.

  

  

  RECITALS

  

  

  WHEREAS, the certain of the Investors (the “Prior Investors”) are holders of the Company’s Series A Preferred Shares, Series B Preferred Shares and/or Voting Common Shares issued upon conversion thereof;

  

  

  WHEREAS, certain of the Prior Investors and the
      Company are parties to an Investors Rights Agreement dated July 29, 2015 (the “Prior Agreement”);

  

  

  WHEREAS, pursuant to the Series C Preferred Share
      Purchase Agreement of even date herewith (the “Series C Purchase Agreement”),

      by and among the Company and certain Investors party thereto (the “Series C Investors”), the Series C Investors have agreed to purchase Series C Preferred Shares
      (defined below) from the Company;

  

  

  WHEREAS, it is a condition to the obligations of
      the Series C Investors pursuant to the Series C Purchase Agreement that the parties hereto execute and deliver this Agreement which amends and restates the Prior Agreement; and

  

  

  WHEREAS, in accordance with Section 3.6 of the
      Prior Agreement, (i) the Company, and (ii) the holders of at least a majority of the then-outstanding Registrable Securities (as defined in the Prior Agreement), desire to enter into this Agreement and to amend and restated the Prior Agreement.

  

  

  NOW, THEREFORE, the parties hereby agree as
      follows:

  

  

  1. Definitions.  For purposes of this Agreement:

   

    

  1.1          “Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including
      without limitation any general partner, managing member, officer or
      director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or
      shares the same management company with, such Person.

  

  

  1.2          “Common Shares” means the Company’s Common Shares, no par value per share.

  
    
      

  

  
  

  

  1.3          “Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act, or other federal or state law,
      insofar as such loss, damage, claim or liability (or any action in respect thereof) arises out of or is based upon: (i) any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company,
      including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the
      statements therein not misleading; or (iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any state
      securities law.

  

  

  1.4          “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

  

  

  1.5          “Excluded Registration” means (i) a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule
          145 transaction; (iii) a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv) a registration in
          which the only shares of the Company’s capital stock being registered is capital stock of the Company issuable upon conversion of debt securities that are also being registered.

  

  

  1.6          “Form S‐1” means such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities
          Act subsequently adopted by the SEC.

  

  

  1.7          “Form S‐3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits
      incorporation of substantial information by reference to other documents filed by the Company with the SEC.

  

  

  1.8          “GAAP” means generally accepted accounting principles in the United States.

  

  

  1.9          “Holder” means any holder of Registrable Securities who is a party to this Agreement.

  

  

  1.10          “Immediate Family Member” means including the spouse, any lineal descendent, parent, grandparent, sibling, nephew or niece, including
      adoptive relationships, relationships by marriage and any person sharing the undersigned’s household (other than a tenant or employee), of a natural person referred to herein

  

  

  1.11          “Initiating Holders” means, collectively, Holders who properly initiate a registration request under this Agreement.

  
    2

    
      

  

  

  

  1.12          “IPO” means the Company’s first underwritten public offering of its shares of capital stock of the Company under the
          Securities Act.

  

  

  1.13          “Person” means any individual, corporation, partnership, trust, limited liability company, association or other entity.

  

  

  1.14          “Preferred Shares” means, collectively, Company’s Series  A Preferred Shares, Series B Preferred Shares and Series C Preferred Shares.

  

  

  1.15          “Registrable Securities” means (i) the Voting Common Shares issuable or issued upon conversion of the Preferred Shares; and (ii) any Common Shares and Voting Common Shares issued as (or issuable upon the conversion or exercise of any
        warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clause (i)
        above, including without limitation any securities issued in exchange for the Preferred Shares in connection with any corporate restructuring or reorganization; excluding in all cases, however, any Registrable Securities sold by a Person in a
        transaction in which the applicable rights under this Agreement are not assigned pursuant to Subsection 3.1, and excluding for purposes of Section 2 any shares for which registration rights have terminated pursuant to Subsection 2.13 of this Agreement.

  

  

  1.16          “Registrable Securities then outstanding” means the number of shares determined by adding the number of outstanding Voting Common Shares that are Registrable Securities and the number of Voting Common Shares issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities that are Registrable Securities.

  

  

  1.17          “Restated Memorandum” means the Amended and Restated Memorandum of Association of the Company dated as of the date hereof.

  

  

  1.18          “Restricted Securities” means the securities of the Company required to be notated with the legend set forth in Subsection
        2.12(b) hereof.

  

  

  1.19          “SEC” means the U.S. Securities and Exchange Commission.

  

  

  1.20          “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.

  

  

  1.21          “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act.

  

  

  1.22          “Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

  

  

  1.23          “Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for
      any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in Subsection 2.6.

  
    3

    
      

  

  

  

  1.24          “Series A Preferred Shares” means the Company’s Series A Preferred Shares, no par value per share.

  

  

  1.25          “Series B Preferred Shares” means the Company’s Series B Preferred Shares, no par value per share.

  

  

  1.26          “Series C Preferred Shares” means the Company’s Series C Preferred Shares, no par value per share.

  

  

  1.27          “Voting Common Shares” means the Company’s Voting Common Shares, no par value per share.

  

  

  2.
                 Registration Rights.  The Company covenants and agrees as follows:

   

    

      2.1
                     Demand Registration.

   

    

  (a)          Form S-1 Demand.  If at any time after one hundred eighty (180) days following the
      effective date of the registration statement for the IPO, the Company receives a request from Holders of at least fifty percent (50%) of the Registrable Securities then outstanding that the Company file a Form S-1 registration statement with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate
        offering price, net of Selling Expenses, of at least $10,000,000, then the Company shall (i) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”) to all Holders other than the Initiating Holders; and (ii) as soon as practicable, and in any event within sixty (60) days after the date such request is given by the Initiating Holders, use
      commercially reasonable efforts to file a Form S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to
      be registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to
        the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Subsections 2.1(c) and 2.3.

  

  

  (b)          Form S-3 Demand.  If at any time when it is eligible to use a Form S-3 registration statement,
        the Company receives a request from Holders of at least fifty percent (50%) of the Registrable Securities then outstanding that the Company file a Form S-3 registration statement with respect to outstanding Registrable Securities of such Holders
        having an anticipated aggregate offering price, net of Selling Expenses, of at least $5,000,000, then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other than the Initiating
        Holders; and (ii) as soon as practicable, and in any event within forty-five (45) days after the date such request is given by the Initiating Holders, use commercially reasonable efforts to file a Form S-3 registration statement under the
        Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given,
        and in each case, subject to the limitations of Subsections 2.1(c) and 2.3.

  
    4

    
      

  

  

  

  (c)          Notwithstanding the foregoing obligations, if the
      Company furnishes to Holders requesting a registration pursuant to this Subsection 2.1 a
      certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Company’s Board of Directors it would be materially detrimental to the Company and its members for such registration statement to either become
      effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially interfere with a significant acquisition, corporate reorganization, or other similar
      transaction involving the Company; (ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the Company unable to comply with requirements under the
      Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more
      than ninety (90) days after the request of the Initiating Holders is given; provided, however,
      that the Company may not invoke this right more than once in any twelve (12) month period; and provided further
      that the Company shall not register any securities for its own account or that of any other member during such ninety (90) day period other than pursuant to a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; a registration on any form that does not include substantially the same
          information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or a registration in which the only capital stock of the Company being registered is capital stock of the Company
          issuable upon conversion of debt securities that are also being registered.

  

  

  (d)          The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1(a), (i) during the period that is sixty (60) days
      before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty (180) days after the effective date of, a Company-initiated registration, provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (ii)
        after the Company has effected two registrations pursuant to Subsection 2.1(a); (iii) if the Initiating Holders propose to dispose of shares of Registrable
        Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to Subsection 2.1(b), or (iv) in any jurisdiction in which the Company would be required
        to execute a general consent to service of process in effectuating such registration, unless the Company is already subject to service of process in such jurisdiction and except as may be required under the Act.  The Company shall not be obligated
        to effect, or to take any action to effect, any registration pursuant to Subsection 2.1(b) (i) during the period that is thirty (30) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration, provided that the Company is actively employing in
        good faith commercially reasonable efforts to cause such registration statement to become effective; (ii) if the Company has effected two registrations pursuant to Subsection 2.1(b) within the twelve (12) month period immediately preceding the date of such request, or (iii) in any jurisdiction in which the Company would be required to
        execute a general consent to service of process in effectuating such registration, unless the Company is already subject to service of process in such jurisdiction and except as may be required under the Act.  A registration shall not be counted as “effected” for purposes of this Subsection

          2.1(d) until such time as the applicable registration statement has been declared effective by
        the SEC, unless the Initiating Holders withdraw their request for such registration, elect not to pay the registration expenses therefor, and forfeit their right to one
          demand registration statement pursuant to Subsection 2.6, in which case such withdrawn registration statement shall be counted as “effected” for purposes of this Subsection 2.1(d).

  
    5

    
      

  

  

  

      2.2   Company Registration.  If the Company proposes to register
      (including, for this purpose, a registration effected by the Company for members other than the Holders) any of its securities under the Securities Act in connection with the public offering of such securities solely for cash (other than in an
      Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration.  Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to
      the provisions of Subsection 2.3, use commercially reasonable efforts to cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration.  The Company shall have the right to
      terminate or withdraw any registration initiated by it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration.  The expenses
      (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance with Subsection 2.6.

   

        

      2.3   Underwriting Requirements.

   

    

  (a)          If, pursuant to Subsection 2.1, the Initiating
      Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their
      request made pursuant to Subsection 2.1, and the Company shall include such information in the Demand Notice.  The underwriter(s) will be selected by the Company
      and shall be reasonably acceptable to a majority in interest of the Initiating Holders.  In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s participation
      in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein.  All Holders proposing to distribute their securities through such underwriting shall (together with the Company as
      provided in Subsection 2.4(e)) enter into an underwriting agreement in customary form with the
      underwriter(s) selected for such underwriting.  Notwithstanding any other provision of this Subsection 2.3, if the underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the
      Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable
      Securities owned by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however, that the number of Registrable Securities held by the Holders to be included in
      such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting.

  
    6

    
      

  

  

  

  (b)          In connection with any offering involving an
      underwriting of shares of the Company’s capital stock pursuant to Subsection 2.2, the Company
      shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the
      underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company.  If the total number of securities, including Registrable Securities, requested by members to be included in such offering exceeds the
      number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number
      of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering.  If the underwriters determine that less than all of the Registrable
      Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities owned by each selling Holder
        or in such other proportions as shall mutually be agreed to by all such selling Holders.  Notwithstanding the foregoing, in no event shall (i) the number of Registrable
          Securities included in the offering be reduced unless all other securities (other than securities to be sold by the Company) are first entirely excluded from the offering, or (ii) the number of Registrable Securities included in the
        offering be reduced below thirty percent (30%) of the total number of securities included in such offering, unless such offering is the IPO, in which case the selling Holders may be excluded further if the underwriters make the determination
        described above and no other member’s securities are included in such offering.  For purposes of the provision in this Subsection 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation,
        the partners, members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the
      benefit of any of the foregoing Persons, shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons
      included in such “selling Holder,” as defined in this sentence.

  

  

  (c)          For purposes of Subsection 2.1, a registration
      shall not be counted as “effected” if, as a result of an exercise of the underwriter’s cutback provisions in Subsection 2.3(a), fewer than fifty percent (50%) of the total number of Registrable Securities that Holders have requested to be included in such registration statement are actually included.

  
    7

    
      

  

  

  

      2.4 Obligations of the Company.  Whenever required under this Section
      2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:

   

    

  (a)          prepare and file with the SEC a registration statement
      with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder,
      keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder
      refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any securities included in such registration, and (ii) in the case of any registration of Registrable Securities on Form S-3 that are
      intended to be offered on a continuous or delayed basis, the Company shall keep the registration statement effective until all such Registrable Securities are sold, provided that the Securities Act permits offering on a continuous or delayed basis;

  
    8

    
      

  

  

  

  (b)          prepare and file with the SEC such amendments and
      supplements to such registration statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such
      registration statement;

  

  

  (c)          furnish to the selling Holders such numbers of copies
      of a prospectus, including a preliminary prospectus, as required by the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities;

  

  

  (d)          use its commercially reasonable efforts to register
      and qualify the securities covered by such registration statement under such other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such
      jurisdiction and except as may be required by the Securities Act;

  

  

  (e)          in the event of any underwritten public offering,
      enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the underwriter(s) of such offering;

  

  

  (f)          use its commercially reasonable efforts to cause all
      such Registrable Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then
      listed;

  

  

  (g)          provide a transfer agent and registrar for all
      Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration;

  

  

  (h)          promptly make available for inspection by the selling
      Holders, any underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by
      any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all
      information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to
          verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith;

  

  

  (i)          notify each selling Holder, promptly after the Company
      receives notice thereof, of the time when such registration statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and

  

  

  (j)          after such registration statement becomes effective,
      notify each selling Holder of any request by the SEC that the Company amend or supplement such registration statement or prospectus.

  
    9

    
      

  

  

  

  In addition, the Company shall ensure that, at all times after any registration statement covering a public offering of securities of the
      Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s directors may implement a trading program under Rule 10b5-1 of the Exchange Act.

  

  

      2.5 Furnish Information.  It shall be a condition precedent to the
      obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable
      Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities.

   

    

      2.6 Expenses of Registration.  All expenses (other than Selling
      Expenses) incurred in connection with registrations, filings, or qualifications pursuant to Section 2, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel for the Company; and
      the reasonable fees and disbursements of one counsel for the selling Holders (selected by
          Holders of a majority of the Registrable Securities to be included in such registration) (“Selling Holder Counsel”), shall be borne and paid by the
      Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Subsection 2.1 if the registration request is subsequently withdrawn at the request of
      the Holders of a majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration),
      unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Subsections 2.1(a) or 2.1(b),
      as the case may be; provided further that if, at the time of such withdrawal, the Holders shall have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the
      time of their request and have withdrawn the request with reasonable promptness after learning of such information then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one registration pursuant to Subsections

        2.1(a) or 2.1(b).  All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on
      their behalf.

   

    

      2.7 Delay of Registration.  No Holder shall have any right to obtain
      or seek an injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2.

   

    

  
    10

    
      

  

      2.8 Indemnification.  If any Registrable Securities are included in a
      registration statement under this Section 2:

   

    

  (a)          To the extent permitted by law, the Company will
      indemnify and hold harmless each selling Holder, and the partners, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each
      such Holder; and each Person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other
      aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which
      Damages may result, as such expenses are incurred; provided, however, that the indemnity
      agreement contained in this Subsection 2.8(a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the
      consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written
      information furnished by or on behalf of any such Holder, underwriter, controlling Person, or other aforementioned Person expressly for use in connection with such registration.

  

  

  (b)          To the extent permitted by law, each selling Holder,
      severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities
      Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against
      any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in
      connection with such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Subsection 2.8(b) shall not apply to amounts paid in settlement of
      any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be
      unreasonably withheld; and provided further that in no event shall the aggregate amounts
      payable by any Holder by way of indemnity or contribution under Subsections 2.8(b) and 2.8(d) exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such
        Holder), except in the case of fraud or willful misconduct by such Holder.

  

  

  (c)          Promptly after receipt by an indemnified party under
      this Subsection 2.8 of notice of the commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any
      indemnifying party under this Subsection 2.8, give the indemnifying party notice of the commencement thereof.  The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate
      jointly with any other indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one 
      separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests
      between such indemnified party and any other party represented by such counsel in such action.  The failure to give notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party
      of any liability to the indemnified party under this Subsection 2.8, to the extent that such failure materially prejudices the indemnifying party’s ability to defend such action.  The failure to give notice to the indemnifying party will not relieve
      it of any liability that it may have to any indemnified party otherwise than under this Subsection 2.8.

  
    11

    
      

  

  

  

  (d)          To provide for just and equitable contribution to
      joint liability under the Securities Act in any case in which either: (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Subsection

        2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the
      denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Subsection 2.8 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Subsection 2.8,
      then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative
      fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that resulted in such loss,
      claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations.  The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the
      untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access
      to information, and opportunity to correct or prevent such statement or omission; provided, however,
      that, in any such case (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (y) no Person guilty
      of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Subsection 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Subsection 2.8(b), exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder.

  

  

  (e)          Notwithstanding the foregoing, to the extent that the
      provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall
      control.

  

  

  (f)          Unless otherwise superseded by an underwriting
      agreement entered into in connection with the underwritten public offering, the obligations of the Company and Holders under this Subsection 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall survive the termination of this Agreement.

  
    12

    
      

  

  

  

      2.9 Reports Under Exchange Act.  With a view to making available to
      the Holders the benefits of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S‐3, the Company
      shall:

   

    

  (a)          make and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all times after the effective date of the registration
      statement filed by the Company for the IPO;

  

  

  (b)          use commercially reasonable efforts to file with the
      SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and

  

  

  (c)        furnish to any Holder, so long as the Holder owns any
      Registrable Securities, forthwith upon request (i) to the extent accurate, a written statement by the Company that it has complied with the reporting
      requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the IPO), the Securities Act, and the Exchange Act (at any time after the Company has become subject to
      such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S‐3 (at any time after the Company so qualifies); (ii) a copy of the most recent annual or quarterly report of the Company and such
      other reports and documents so filed by the Company; and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at
      any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form S‐3 (at any time after the Company so qualifies to use such form).

  

  

      2.10  Limitations on Subsequent Registration Rights.  From and after the date of this Agreement, the Company shall not, without the prior written consent of the
      Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that (i) would provide to such holder the right to include securities in any
      registration on other than either a pro rata basis with respect to the Registrable Securities or on a subordinate basis after all Holders have had the opportunity to include in the registration and offering all shares of Registrable Securities that
      they wish to so include; or (ii) allow such holder or prospective holder to initiate a demand for registration of any securities held by such holder or prospective holder; provided that this limitation shall not apply to any additional Investor who becomes a party to this Agreement in accordance with Subsection 3.9.

  
    13

    
      

  

      2.11 “Market Stand‐off” Agreement. Each

        Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company for its own behalf of its Common Shares, Voting Common Shares or any other equity securities under the Securities Act on a registration statement on Form S-1 or Form F-1, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days in
          the case of the IPO, (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant
        any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any Voting Common Shares or any securities convertible into or exercisable or exchangeable (directly or indirectly) for shares of the Company’s capital stock held immediately before the effective date of the
        registration statement for such offering or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
        consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Voting Common Shares
        or other securities, in cash, or otherwise.  The foregoing provisions of this Subsection 2.11 shall apply only to the IPO, shall not apply to the sale of any
        shares to an underwriter pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of the Holder or the immediate
          family of the Holder, provided that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further that any such transfer shall not involve a disposition for value, and

        shall be applicable to the Holders only if all officers and directors are subject to the same restrictions and the Company uses commercially reasonable efforts to obtain a similar agreement from all members individually owning more than one percent
        (1%) of the Company’s outstanding capital stock (after giving effect to conversion into Voting Common Shares of all outstanding Preferred Shares).  The underwriters in connection with such registration are intended third‐party beneficiaries of this Subsection 2.11 and shall have the right, power and authority to enforce
        the provisions hereof as though they were a party hereto.  Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection

          with such registration that are consistent with this Subsection 2.11 or that are necessary to give further effect thereto.

   

    

      2.12 Restrictions on Transfer.

   

    

  (a)          The Preferred Shares and the Registrable Securities
      shall not be sold, pledged, or otherwise transferred, and the Company shall not recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in
      this Agreement, as well as the terms and conditions of the Restated Memorandum, which conditions are intended to ensure compliance with the provisions of the Securities Act.  A transferring Holder will cause any proposed purchaser, pledgee, or
      transferee of the Preferred Shares and the Registrable Securities held by such Holder to agree to take and hold such securities subject to the provisions and upon the conditions specified in this Agreement.

  
    14

    
      

  

  

  

  (b)          Each certificate, instrument, or book entry representing (i) the Preferred Shares, (ii) the Registrable Securities, and (iii) any other securities issued in respect of the securities
        referenced in clauses (i) and (ii), upon any share split, share dividend, recapitalization, merger, consolidation, or similar event, shall be notated with a legend substantially

        in the following form:

  

  

  THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933.  SUCH SHARES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE
      ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT.

  

  

  THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE MEMBER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.

  

  

  The Holders consent to the Company making a notation in its records and giving instructions to any transfer agent of the Restricted
      Securities in order to implement the restrictions on transfer set forth in this Subsection 2.12.

  

  

      2.13 Termination of Registration Rights.  The right of any Holder to
      request registration or inclusion of Registrable Securities in any registration pursuant to Subsections 2.1 or 2.2 shall terminate upon the earliest

          to occur of:

   

    

  (a)          the closing of a Qualified Liquidation/Change of
      Control Event, as such term is defined in the Company’s Restated Memorandum; and

  

  

  (b)          the fifth anniversary of the IPO.

  

  

  3. Miscellaneous

   

  

   

          

   

          

  3.1    3.1  Successors and Assigns.  The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Immediate Family Member or trust for the
          benefit of an individual Holder or one or more of such Holder’s Immediate Family Members; or (iii) after such transfer, holds at least 500,000 shares of Registrable Securities (subject to appropriate adjustment for share splits, share dividends,
          combinations, and other recapitalizations); provided, however, that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the Registrable
          Securities with respect to which such rights are being transferred; and (y) such
          transferee agrees in a written instrument delivered to the Company to be bound by and

          subject to the terms and conditions of this Agreement, including the provisions of
          Subsection 2.11.  For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1)
          that is an Affiliate or stockholder of a Holder; (2) who is a Holder’s Immediate Family Member; or (3) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of
          the transferring Holder; provided further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking
          any action under this Agreement.  The terms and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties.  Nothing in this Agreement, express or implied, is
        intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein.

  
    15

    
      

  

   

    

      3.2 Governing Law.  This Agreement shall be governed by the internal
      law of the California.

   

        

      3.3 Counterparts.  This Agreement may be executed in two (2) or more
      counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Counterparts

          may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
        www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all
          purposes.

   

      

      3.4 Titles and Subtitles.  The titles and subtitles used in this
      Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement.

  

  

      3.5 Notices.  All notices and other communications given or made
      pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or (i) personal delivery to the party to be notified; (ii) when sent, if sent by  electronic mail or facsimile during the
      recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv)
      one (1) business day after the business day of
        deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of receipt.  All communications shall be sent to the respective parties at their addresses as set forth on Schedule
          A hereto, or to the principal office of the Company and to the attention of the Chief Executive Officer, in the case of the Company, or to such email address,
        facsimile number, or address as subsequently modified by written notice given in accordance with this Subsection 3.5.  If notice is given to the Company, a copy shall
        also be sent to Jones Day, 12265 El Camino Real, Suite 300, San Diego, California, 92130, Attention: Kenneth D. Polin, and if notice is given to Members, a copy shall also be given to Goodwin Procter LLP, 53 State Street, Boston, Massachusetts,
        02109, Attention: Lawrence S. Wittenberg.

   

    

      3.6 Amendments and Waivers.  Any term of this Agreement may be amended
      and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders of a majority of the Registrable
      Securities then outstanding; and provided further that any provision hereof may be waived by any waiving party on such
          party’s own behalf, without the consent of any other party.  Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without
      the written consent of such Investor, unless such amendment, termination, or waiver applies to all Investors in the same fashion.  Any amendment, termination, or waiver effected in accordance with this Subsection

          3.6 shall be binding on
      all parties hereto, regardless of whether any such party has consented thereto.  No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or
      continuing waiver of any such term, condition, or provision.

  
    16

    
      

  

   

    

      3.7   Severability.  In case any one or more of the provisions
      contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or
      unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law.

   

    

      3.8 Aggregation of Shares.  All shares of Registrable Securities held
      or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate.

   

    

      3.9 Additional Investors.  Notwithstanding anything to the contrary
      contained herein, if the Company issues additional Series C Preferred Shares after the date hereof, whether pursuant to the Series C Purchase Agreement or otherwise, any purchaser of such Series C Preferred Shares may become a party to this Agreement
      by executing and delivering an additional counterpart signature page to this Agreement, and thereafter shall be deemed an “Investor” for all purposes hereunder.  Furthermore, holders of the Company’s Series A Preferred Shares may become a party to
      this Agreement by executing and delivering an additional counterpart signature page to this Agreement, and shall thereafter be deemed an “Investor” for all purposes hereunder.  No action or consent by the Investors shall be required for such joinder
      to this Agreement by such additional Investor, so long as such additional Investor
      has agreed in writing to be bound by all of the obligations as an “Investor” hereunder.

   

    

      3.10 Entire Agreement.  This Agreement (including any Schedules
      hereto) constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral
      agreement relating to the subject matter hereof existing between the parties is expressly canceled.

   

    

      3.11 Dispute Resolution.  The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of New York and to the jurisdiction of the
      United States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or
      based upon this Agreement except in the state courts of New York or the United States District Court for the Southern District of New York, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit,
      action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient
      forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

  
    17

    
      

  

   

    

  WAIVER OF JURY TRIAL: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY
      TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF.  THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL
      DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY
      CLAIMS.  THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS.  EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL
      COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

  

  

   The prevailing party shall be entitled to reasonable attorney’s fees, costs, and necessary disbursements in addition to any other relief
      to which such party may be entitled. Each of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the Southern District of New York or any court of the State of New York having
      subject matter jurisdiction.

  

  

      3.12 Delays or Omissions.  No delay or omission to exercise any right,
      power, or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to
      be a waiver of or acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter
      occurring.  All remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

   

    

      3.13 Acknowledgment.  The Company acknowledges that the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many
          enterprises, including enterprises which may have products or services which compete directly or indirectly with those of the Company.  Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating
          in any particular enterprise whether or not such enterprise has products or services which compete with those of the Company.

   

        

  [Remainder of Page Intentionally Left Blank]

  
    18

    
      

  

  

  

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

  

  	 	
          CIBUS GLOBAL, LTD.

        
	 	 	 
	 	
          By:

        	/s/ Peter Beetham
	 	
          Name:

        	
          Peter Beetham

        
	 	
          Title:

        	
          President & CEO

        

  

  

  
    
      

  

  

  	 	
          INVESTORS

        
	 	 
	 	
          /s/ Rory Riggs

        
	 	
          Name: Rory Riggs

        
	 	 
	 	
          /s/ Jean-Pierre Lehmann

        
	 	
          Name:  Jean-Pierre Lehmann

        
	 	 
	 	
          /s/ Donald R. Samuels

        
	 	
          Name:  Donald R. Samuels

        
	 	 
	 	
          /s/ Michael Kempner

        
	 	
          Name:  Michael Kempner

        
	 	 
	 	
          /s/ William S. Adams

        
	 	
          Name:  William S. Adams

        
	 	 
	 	
          /s/ Peter Beetham

        
	 	
          Name:  Peter Beetham

        
	 	 
	 	
          /s/ Robert G. Easton

        
	 	
          Name:  Robert G. Easton

        
	 	 
	 	
          /s/ Andrea N. Sehl

        
	 	
          Name:  Andrea N. Sehl

        
	 	 
	 	
          /s/ John V. Koerber

        
	 	
          Name:  John V. Koerber

        
	 	 
	 	
          MAF Management Ltd.

           

          /s/ Michael H. Freedman

        
	 	
          Name: Michael H. Freedman

        
	 	 
	 	
          /s/ Christos Richards

        
	 	
          Name: Christos Richards

        
	 	 
	 	
          /s/ Sean O’Connor

        
	 	
          Name: Sean O’Connor

        
	 	 
	 	
          /s/ Kenneth L. Lynch

        
	 	
          Name: Kenneth L. Lynch

        

   

  

  
    
      

  

  

  

  	 	
          /s/ Paul Pullins

        
	 	
          Name: Paul Pullins

        
	 	 
	 	
          William C. Eacho Revocable Trust

           

          /s/ William C. Eacho

        
	 	
          Name: William C. Eacho

        
	 	 
	 	
          /s/ Mark Tallis

        
	 	
          Name: Mark Tallis

        
	 	 
	 	
          Crown Global Life Insurance Ltd IRO Separate Account 3000

           

          /s/ Terria Godwin   

              /s/Suzanne Reynolds

        
	 	
          Name:  Terria Godwin   

              Name:  Suzanne Reynolds

        
	 	 
	 	
          Baxter Partners L.P.

           

          /s/ F.H. Weymor

        
	 	
          Name: F.H. Weymor

        
	 	 
	 	
          DJG Associated LLC

           

          /s/ Drew J. Gutt

        
	 	
          Name: Drew J. Gutt

        
	 	 
	 	
          RS & RSDT Investment Vehicle

           

          /s/ Ricky Sandler

        
	 	
          Name: Ricky Sandler

        
	 	 
	 	
          The Mara & Ricky Sandler Foundation

           

          /s/ Ricky Sandler

        
	 	
          Name: Ricky Sandler

        
	 	 
	 	
          Cormorant Global Healthcare Master Fund, L.P

           

          /s/ Biluia Chen

        
	 	
          Name: Biluia Chen

        

  
    
      

  

  

  

  	 	
          Cormorant Private Healthcare Fund I, L.P.

           

          /s/ Biluia Chen

        
	 	
          Name: Biluia Chen

        
	 	 
	 	
          CRMA SPV, L.P.

           

          /s/ Biluia Chen

        
	 	
          Name: Biluia Chen

        
	 	 
	 	
          Alexandria Equities No. 7, LLC

          By: ARE-Special Services, LLC

          A Delaware limited liability company (Managing Member)

           

          By: ALEXANDRIA REAL ESTATE EQUITIES, L.P.,

          A Delaware limited liability company (Managing Member)

           

          By: ARE-ORS CORP,

          A Maryland corporation

          (General Partner)

           

          /s/ Aaron Jacobson

        
	 	
          Name: Aaron Jacobson

        
	 	 
	 	
          /s/ William B. Campbell

        
	 	
          Name: William B. Campbell

        
	 	 
	 	
          /s/ F. Paul Mooney, Jr.

        
	 	
          Name: F. Paul Mooney, Jr.

        
	 	 
	 	
          /s/ Ward Mooney

        
	 	
          Name: Ward Mooney

        
	 	 
	 	
          /s/ Roland A. DeSilva

        
	 	
          Name: Roland A. DeSilva

        
	 	 
	 	
          /s/ Scott Donahue

        
	 	
          Name: Scott Donahue

        
	 	 
	 	
          /s/  Inigo Joaquin Espinosa de los Monteros

        
	 	
          Name:  Inigo Joaquin Espinosa de los Monteros

        
	 	 
	 	
          /s/ George Keelan

        
	 	
          Name: George Keelan

        
	 	 
	 	
          /s/ Dennis Mensch

        
	 	
          Name: Dennis Mensch

        
	 	 
	 	
          /s/ Jeffrey William Henderson

        
	 	
          Name: Jeffery William Henderson

        
	 	 
	 	
          /s/ Thomas Keelan

        
	 	
          Name: Thomas Keelan

        
	 	 
	 	
          Gerardo Lema 2003 Trust

           

          /s/ Gerardo Lema

        
	 	
          Name: Gerardo Lema

        
	 	 
	 	
          /s/ Araceli Navarro

        
	 	
          Name: Araceli Navarro

        
	 	
          PQN Holdings Ltd.

           

          /s/ Susan V. Demers

        
	 	
          Name: Susan V. Demers for Vicali Services (BVI) Inc.

        
	 	 
	 	
          The Diana L. Wege Revocable Trust U/A/D October 12, 2016

           

          /s/ Diana L. Wege

        
	 	
          Name: Diana L. Wege

        
	 	 
	 	
          /s/ Georges Hibon

        
	 	
          Name:  Georges Hibon

        

  

  

  
    
      

  

  	 	 
	 	
          /s/ Mark L. Hart III

        
	 	
          Name: Mark L. Hart III

        
	 	 
	 	
          Hinrichs Joint Revocable Trust DTD 9/20/2013

           

          /s/ James F. Hinrichs    

              /s/ Felicia J. Hinrichs

        
	 	
          Name: James F. Hinrichs    

              Name: Felicia J. Hinrichs

        
	 	 
	 	
          /s/ Almudena Legorreta

        
	 	
          Name: Almudena Legorreta

        
	 	 
	 	
          /s/ Tom Pizzey

        
	 	
          Name: Tom Pizzey

        

  

  

  
    
      

  

  	 	 
	 	
          PLA Fund, LLC

           

          /s/ Pablo Legorreta

        
	 	
          Name: Pablo Legorreta

        
	 	 
	 	
          /s/ James F. Reddoch

        
	 	
          Name: James F. Reddoch

        
	 	 
	 	
          /s/ Jonathan Wray Sweet

        
	 	
          Name: Jonathan Wray Sweet

        
	 	 
	 	
          /s/ Joseph P. Von Meister

        
	 	
          Name: Joseph P. Von Meister

        
	 	 
	 	
          FSGRWCO CB Holdings LLC

           

          By: Fidelity Mt. Vernon Street Trust – Fidelity Series Growth Company Fund, its Manager

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        
	 	 
	 	
          GRTHCOCP CB Holdings LLC

           

          By: Fidelity Growth Company Commingled Pool, its Manager

           

          By: Fidelity Management Trust Company, as Trustee

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        
	 	 
	 	
          GROWTHCO CB Holdings LLC

           

          By: Fidelity Mt. Vernon Street Trust – Fidelity Growth Company Fund, its Manager

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        
	 	 
	 	
          BCGF CB Holdings LLC

           

          By Fidelity Securities Fund – Fidelity Blue Chip Growth Fund, its Manager

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        

  
    
      

  

  

  

  	 	
          BCGFCP CB Holdings LLC

          

              By: Fidelity Blue Chip Growth Commingled Pool, its Manager

           

          By: Fidelity Management Trust Company, as Trustee

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        
	 	 
	 	
          BCGFK CB Holdings LLC

           

          By: Fidelity Securities Fund – Fidelity Blue Chip Growth K6 Fund, its Manager

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        
	 	 
	 	
          FSBCGF CB Holdings LLC

           

          By: Fidelity Securities Fund – Fidelity Sales Blue Chip Growth Fund, its Manager

           

          /s/ Colm Hogan

        
	 	
          Name: Colm Hogan

        
	 	 
	 	
          PYLBCG CB Holdings LLC

           

          By: FIAM Target Date Blue Chip Growth Commingled Pool, its Manager

           

          By: Fidelity Institutional Asset Management Trust Company, as Trustee

           

          /s/ Adrieu Deberghes

        
	 	
          Name: Adrieu Deberghes

        
	 	 
	 	
          Able Convention Market Research, DB

           

          /s/ Byron Scot Astor

        
	 	
          Name: Byron Scot Astor

        
	 	 
	 	
          Advanta IRA Administration, LLC FBO Lauren M. Jones IRA #1522633

           

          /s/ Paul Hutchings

        
	 	
          Name: Paul Hutchings

        

  

  

  
    
      

  

  	 	 
	 	
          Bain Family Living Trust

           

          /s/ John E. Bain, TTE     

              /s/ Laura Bain

        
	 	
          Name: John E. Bain, TTE     

              Name: Laura Bain

        
	 	 
	 	
          /s/ John E. Bain

        
	 	
          Name: John E. Bain

        
	 	 
	 	
          /s/ Philip A. Band

        
	 	
          Name: Philip A. Band

        
	 	 
	 	
          /s/ Kevin P. Barr

        
	 	
          Name: Kevin P. Barr

        
	 	 
	 	
          /s/ Jennifer Barrett

        
	 	
          Name: Jennifer Barrett

        
	 	 
	 	
          /s/ Patricia Bennett-Perry

        
	 	
          Name: Patricia Bennett-Perry

        
	 	 
	 	
          Bennett Investment Protection 1, LLC

           

          /s/ James G. Bennett III

        
	 	
          Name: James G. Bennett III

        
	 	 
	 	
          /s/ Ursula Boornazian   

          /s/ S. Aram Boornazian

        
	 	
          Name: Ursula Boornazian   

              Name: S. Aram Boornazian

        
	 	 
	 	
          The Burkhart Mazzola Family Trust

           

          /s/ James Mazzola   

          /s/ Davidde Burkhart

        
	 	
          Name: James Mazzola   

              Name: Davidde Burkhart

        
	 	 
	 	
          Catherine Blanchard 2004 Irrevocable Trust

           

          /s/ Edward V. Blanchard, Jr.

        
	 	
          Name: Edward V. Blanchard, Jr.

        

  

  

  
    
      

  

  	 	 
	 	
          /s/ Dennis L. Charles   

              /s/ Leslie A. Charles

        
	 	
          Name: Dennis L. Charles   

              Name: Leslie A. Charles

        
	 	 
	 	
          Day-Jones Enterprises, LLC

           

          /s/ Edward V. Blanchard, Jr.

        
	 	
          Name: Edward V. Blanchard, Jr.

        
	 	 
	 	
          /s/ Kieran Gallahue

        
	 	
          Name: Kieran Gallahue

        
	 	 
	 	
          Hinrichs Joint Revocable Trust

           

          /s/ James F. Hinrichs

        
	 	
          Name: James F. Hinrichs

        
	 	 
	 	
          KT Investments II, LLC

           

          /s/ Kenneth Z. Slater

        
	 	
          Name: Kenneth Z. Slater

        
	 	 
	 	
          Lydia Blanchard 2003 Irrevocable Trust

           

          /s/ Edward V. Blanchard, Jr.

        
	 	
          Name: Edward V. Blanchard, Jr.

        
	 	 
	 	
          MAH Credit Shelter trust

           

          /s/ Edward V. Blanchard, Jr.

        
	 	
          Name: Edward V. Blanchard, Jr.

        
	 	 
	 	
          Business Marketing Group DBP

           

          /s/ John F. Mauldin

        
	 	
          Name: John F. Mauldin

        
	 	 
	 	
          Mauldin Management DBP

           

          /s/ John F. Mauldin

        
	 	
          Name:  John F. Mauldin

        
	 	 
	 	
          Number Four, LLC

           

          /s/ Malcolm M. Brown IV

        
	 	
          Name: Malcolm M. Brown IV

        

  
    
      

  

  

  

  	 	
          Optiform Imaging Systems Inc. Retirement Plan & Trust

           

          /s/ Jimmy Middleton

        
	 	
          Name: Jimmy Middleton

        
	 	 
	 	
          /s/ Nancy B. Perkins

        
	 	
          Name: Nancy B. Perkins

        
	 	 
	 	
          Rose Procacci Tax Exempt Trust

           

          /s/ Pasemme M. Procacci

        
	 	
          Name: Pasemme M. Procacci

        
	 	 
	 	
          /s/ Kevin S. Reed

        
	 	
          Name: Kevin S. Reed

        
	 	 
	 	
          /s/ Joseph Rolandelli

        
	 	
          Name: Joseph Rolandelli

        
	 	 
	 	
          /s/ Avi Rutstein

        
	 	
          Name: Avi Rutstein

        
	 	 
	 	
          /s/ Richard W. Schoenfeld

        
	 	
          Name: Richard W. Schoenfeld

        
	 	 
	 	
          /s/ Major Sherwin

        
	 	
          Name: Major Sherwin

        
	 	
          Sophia LLC

           

          /s/ Patrick Beaudan

        
	 	
          Name: Patrick Beaudan

        
	 	 
	 	
          The John A. Studebaker 1991 Trust

           

          /s/ Susan Vrobel

        
	 	
          Name: Susan Vrobel

        
	 	 
	 	
          /s/ Leslie Tcheyan

        
	 	
          Name: Leslie Tcheyan

        
	 	 
	 	
          /s/ Simon Whitten   

              /s/Jacqueline Slater Whitten

        
	 	
          Name: Simon Whitten  

              Name: Jacqueline Slater Whitten

        
	 	 
	 	
          /s/ Sammye Dwight Winstead

        
	 	
          Name: Sammye Dwight Winstead

        

  

  

  

  

  
    
      

  

  SCHEDULE A

  

  

  Investors

  

  

  Rory Riggs

  Jean Pierre Lehmann

  New Ventures Holdings, Inc.

  Crown Global Life Insurance Ltd. IRO Separate Account 30000

  Robert G. Easton

  Stephen Howell

  Baxter Partners LP

  Michael Kempner

  Kenneth L. Lynch

  Anurag Agarwal

  Harry Glorikian

  The Warren & Gail Hall Trust

  Mark P. Tallis

  William S. Adams

  Charles C. Crispin Revocable Trust

  Aram Kaloustian

  Jane Roughton Kearns

  Thomas F. Kearns

  Daniel E. Freier Revocable Trust

  Greg Gocal

  Randall P. Herman Revocable Trust U/A/D/ June 10, 2014

  James Paul Pullins

  RS & RSDT Investment Vehicle, LLC (Chef Burros & Ricky Sandler)

  The Mara and Ricky Sandler Foundation

  The Tully M. Friedman Revocable Trust

  Christos Richards

  Andrea N. Sehl

  Jennifer Barrett

  Thomas J. Killian (minor child of Jennifer Barrett)

  Campbell E. Killian (minor child of Jennifer Barrett)

  Kari Gronberg

  MRB Capital LLC

  Zachary S. Wochok Revocable Trust

  Noriza Ventures, S.A.

  Maria Gaitanou Embiricos

  Peter Beetham

  Sean O’Connor

  Monique Lazard

  Sidney Lazard

  Gerard Pilon

  JG Family Trust

  DG Family Trust

  
    
      

  

  GCM Cibus Offshore Investors, Ltd.

  GCM Cibus Domestic Investors, Ltd.

  Lufam Genertic Biotech Limited

  Rowiss Biotech Investment Limited

  John Koerber

  Scott Donohue

  CRMA SPV, L.P.

  Cormorant Private Healthcare Fund I, L.P.

  Cormorant Global Healthcare Master Fund, L.P.

  Jarvis Slade

  Joan Hornig

  Kevin Reed

  Next Generation TS FBO F. Helmut Weymar IRA 3020

  Dennis Mensch

  Jackie Yu-Chen Lu

  Rosalyn Lu

  Ogle Enterprises, LLC

  Harris Family Trust

  David Soowal

  Joyce Soowal

  Bauke Deinum

  Donald Samuels

  MAF Management Ltd.

  William Eacho Revocable Trust

  Mark Tallis

  DJG Associated LLC

  Alexandria Equities No. 7, LLC

  William Campbell

  Ward Mooney

  Ronald A. DeSilva

  Inigo Joaquin Espinosa de los Monteros

  George Keelan

  Dennis Mensch

  Jeffrey William Henderson

  Thomas Keelan

  John V. Koerber

  Gerardo Lema 2003 Trust

  Araceli Navarro

  PQN Holdings Ltd.

  The Diana L. Wege Revocable Trust U/A/D October 12, 2016

  William S. Adams

  Georges Hibon

  James F. Reddoch

  Tom Pizzey

  Jonathan Wray Sweet

  Joseph von Meister

  
    
      

  

  PLA Fund, LLC

  Mark L. Hart III

  Almudena Legorreta

  Hinrichs Joint Revocable Trust

  FSGRWCO CB Holdings LLC

  GRTHCOCP CB Holdings LLC

  GROWTHCO CB Holdings LLC

  BCGF CB Holdings LLC

  BCGFCP CB Holdings LLC

  PYLBCG CB Holdings LLC

  BCGFK CB Holdings LLC

  FSBCGF CB Holdings LLC

  Simon Whitten & Jacqueline Slater Whitten

  KT Investments II, LLC

  Bennett Investment Protection 1, LLC

  Kieran Gallahue

  Richard Schoenfeld

  The John A. Studebaker 1991 Trust

  Sammye Dwight Winstead

  The Burkhart Mazzola Family Trust

  Joseph Rolandelli

  Mauldin Management DBP

  Business Marketing Group DBP

  Millenium Trust Co., LLC Custodian FBO Optiform Imaging Systems

  Millenium Trust Co., LLC Custodian FBO Major Sherwin

  Advanta IRA Administration, LLC FBO Lauren M. Jones IRA #1522633

  Rose Procacci Tax Exempt Trust

  Sophia LLC

  Number Four, LLC

  Nancy B. Perkins

  Patricia Bennett-Perry

  Avi Rutstein

  Dennis and Leslie Charles

  Aram and Ursula Boornazian

  Kevin Barr

  MAH Credit Shelter Trust

  Lydia Blanchard 2003 Irrevocable Trust

  Catherine Blanchard 2004 Irrevocable Trust

  Day-Jones Enterprises, LLC

  Leslie Tcheyan

  Kevin Reed

  Jennifer Barrett

  Philip Band

  John E. Bain

  Bain Family Living Trust

  Able Convention Market Research, DB

  Sean O’Connor

  Jeffrey Henderson

  Hinrichs Joint Revocable Trust

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]